VeriSIM Life Company
VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials.
Investors
.png)
Technology:
Artificial Intelligence, Health Care, Machine Learning, SaaS
Industry:
Early Drug Development, Preclinical Development
Headquarters:
San Francisco, California, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
15
Total Funding:
21655908
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-01-13
Last Funding Type:
Series A
Register and Claim Ownership